CIP2A protein expression in high-grade, high-stage bladder cancer (Q36530648)

14 August 2017

CIP2A protein expression in high-grade, high-stage bladder cancer (English)

1 reference

14 August 2017

Lisa P Huang

1

1 reference

14 August 2017

Diana Savoly

2

1 reference

14 August 2017

Abraham A Sidi

3

1 reference

14 August 2017

Martin E Adelson

4

1 reference

14 August 2017

Eli Mordechai

5

1 reference

14 August 2017

Jason P Trama

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

15 July 2012

1 reference

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

1

1 reference

14 August 2017

76-81

1 reference

describes a project that uses

14 August 2017

ImageQuant

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3544439/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

CIP2A expression is elevated in cervical cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

CIP2A expression is increased in prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

The role of CIP2A in oral squamous cell carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

CIP2A is associated with human breast cancer aggressivity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

Mechanisms of MYC stabilization in human malignancies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

CIP2A inhibits PP2A in human malignancies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

Susceptibility of cancer cells to herpes simplex virus-dependent apoptosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

30 September 2017

Bladder cancer, 1996.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544439

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

30 September 2017

1 reference

Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy

21 January 2018

1 reference

CIP2A is a predictor of poor prognosis in colon cancer.

21 January 2018

1 reference

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers

21 January 2018

1 reference

The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23342256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23342256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CAM4.15

1 reference

14 August 2017

1 reference

14 August 2017

1 reference